PARPi as the Emerging Treatment Strategy in BRCA+ Metastatic TNBC: Improvement in PFS in Platinum Naive /Sensitive Disease
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Omer Dizdar
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Omer Dizdar
Comments 0
Login to view comments.
Click here to Login